Defining faecal calprotectin thresholds as a surrogate for endoscopic and histological disease activity in ulcerative colitis - a prospective analysis.
Walsh, A; Kormilitzin, A; Hinds, C; Sexton, V; Brain, O; Keshav, S; Uhlig, H; Geddes, J; Goodwin, G; Peters, M; Collins, G; Travis, S;
Journal of Crohn's & colitis (16 November 2018)

Should extraintestinal manifestations (EIMs) be part of disease activity assessment in ulcerative colitis?
Walsh, A; Kormilitzin, A; Hinds, C; Sexton, V; Wilson, J; Brain, O; Keshav, S; Uhlig, H; Geddes, J; Goodwin, G; Peters, M; Collins, G; Travis, S;
JOURNAL OF CROHNS & COLITIS volume 12 page S461-S461 (February 2018) Full text available

New faecal calprotectin cut-off points for remission and active disease defined by UCEIS and Nancy indices in ulcerative colitis (UC)
Walsh, A; Kormilitzin, A; Hinds, C; Sexton, V; Bond, S; Wilson, J; Brain, O; Keshav, S; Uhlig, H; Geddes, J; Goodwin, G; Peters, M; Collins, G; Travis, S;
JOURNAL OF CROHNS & COLITIS volume 12 page S233-S233 (February 2018) Full text available